Bio-Techne Corp - 29 Year Stock Price History | TECH

Historical daily share price chart and data for Bio-Techne Corp since 1992 adjusted for splits. The latest closing stock price for Bio-Techne Corp as of September 27, 2021 is 511.45.
  • The all-time high Bio-Techne Corp stock closing price was 538.88 on September 24, 2021.
  • The Bio-Techne Corp 52-week high stock price is 543.85, which is 6.3% above the current share price.
  • The Bio-Techne Corp 52-week low stock price is 245.40, which is 52% below the current share price.
  • The average Bio-Techne Corp stock price for the last 52 weeks is 389.05.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bio-Techne Corp Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 424.1929 314.6200 538.8800 314.6200 511.4500 61.06%
2020 247.7794 219.4600 321.8700 161.1700 317.5500 44.66%
2019 198.1965 141.9100 222.0900 136.0900 219.5100 51.68%
2018 159.6951 131.4600 204.1100 131.4600 144.7200 11.71%
2017 114.6330 102.6100 134.7500 97.9000 129.5500 25.98%
2016 101.6069 88.2300 115.1700 81.2200 102.8300 14.26%
2015 96.6247 91.4400 111.0600 87.0000 90.0000 -2.60%
2014 90.9403 94.1900 96.6900 83.7400 92.4000 -2.40%
2013 74.5120 69.3400 94.6700 63.4200 94.6700 38.53%
2012 69.6373 68.5800 76.0200 65.1900 68.3400 0.12%
2011 72.4047 66.4900 85.1300 62.3700 68.2600 3.94%
2010 62.1573 68.6800 68.6800 56.1400 65.6700 -4.22%
2009 60.6913 64.4700 69.6500 45.6400 68.5600 6.26%
2008 70.7446 67.1100 81.9000 59.4900 64.5200 -2.32%
2007 60.5362 56.1700 69.9000 54.6800 66.0500 19.12%
2006 54.4261 56.9600 60.1400 45.6300 55.4500 -1.12%
2005 47.1188 38.2900 58.4500 33.1100 56.0800 44.16%
2004 39.2968 38.0000 43.4500 34.9600 38.9000 2.80%
2003 29.3388 28.9900 39.0000 18.9500 37.8400 32.45%
2002 29.8044 35.9900 37.0500 22.7900 28.5700 -22.47%
2001 30.2317 33.6900 38.4100 22.5000 36.8500 2.19%
2000 44.3085 29.2500 74.0000 25.9850 36.0600 30.98%
1999 15.3738 10.5650 27.5300 10.2500 27.5300 160.58%
1998 8.6826 9.2500 10.5650 6.1250 10.5650 19.04%
1997 7.2237 6.2500 9.8750 5.6875 8.8750 36.54%
1996 6.2233 4.9700 7.9375 4.5313 6.5000 29.16%
1995 4.0877 2.5000 6.0325 2.5000 5.0325 96.39%
1994 2.6292 2.5625 3.1250 2.1875 2.5625 -6.82%
1993 3.6056 4.3125 4.6250 2.4688 2.7500 -35.29%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $19.987B $0.931B
Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29